![](https://webarchive.library.unt.edu/eot2008/20081103171325im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081103171325im_/http://www.nci.nih.gov/images/spacer.gif)
| An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells. |
Previous Definitions: | HPV vaccine, HRT, HSIL, HSP, HTLV-1 | Next Definitions: | Hu3S193, HuAFP31, Huang Lian, huC242-DM4, HuHMFG1 |
|
![](https://webarchive.library.unt.edu/eot2008/20081103171325im_/http://www.nci.nih.gov/images/spacer.gif) |